Geraldine Marcenyac

Title: Geraldine Marcenyac: Innovator in Transdermal Delivery Systems

Introduction

Geraldine Marcenyac is a notable inventor based in Norwalk, CT (US), recognized for her contributions to the field of transdermal delivery systems. With a total of three patents to her name, she has made significant advancements in the treatment of various medical conditions through innovative delivery methods.

Latest Patents

Among her latest patents is the "Loratadine transdermal device and methods," which discloses a transdermal delivery device designed to effectively treat seasonal allergic rhinitis and chronic idiopathic urticaria in humans. Another significant patent is the "Terazosin transdermal device and methods," which outlines a method for effectively treating benign prostatic hypertension in humans by administering amorphous terazosin via a transdermal formulation. This formulation is intended to be applied to the skin and maintained in contact for a duration of at least 24 hours, ideally lasting between 3 to 8 days.

Career Highlights

Geraldine has worked with prominent companies such as Purdue Pharma L.P. and Euro-Celtique S.A., where she has applied her expertise in developing innovative medical solutions. Her work has contributed to the advancement of transdermal delivery systems, enhancing patient care and treatment efficacy.

Collaborations

Throughout her career, Geraldine has collaborated with talented individuals, including Lino Tavares and Ihor Shevchuk, who have contributed to her projects and innovations.

Conclusion

Geraldine Marcenyac stands out as a pioneering inventor in the field of transdermal delivery systems, with her patents reflecting her commitment to improving medical treatments. Her work continues to influence the industry and enhance patient outcomes.